THX Pharma
ALTHX.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | – | €1 | €0 | €1 |
| Short-Term Investments | – | €0 | €1 | €4 |
| Receivables | – | €1 | €0 | €0 |
| Inventory | – | €0 | €0 | €0 |
| Other Curr. Assets | – | €1 | €1 | €1 |
| Total Curr. Assets | – | €3 | €3 | €6 |
| Property Plant & Equip (Net) | – | €0 | €0 | €0 |
| Goodwill | – | €0 | €0 | €0 |
| Intangibles | – | €1 | €1 | €1 |
| Long-Term Investments | – | €0 | €0 | €0 |
| Tax Assets | – | €0 | €0 | €0 |
| Other NC Assets | – | €0 | €0 | €0 |
| Total NC Assets | – | €1 | €1 | €1 |
| Other Assets | – | €0 | €0 | €0 |
| Total Assets | – | €4 | €4 | €7 |
| Liabilities | – | – | – | – |
| Payables | – | €1 | €1 | €1 |
| Short-Term Debt | – | €1 | €1 | €1 |
| Tax Payable | – | €0 | €0 | €0 |
| Deferred Revenue | – | €0 | €0 | €0 |
| Other Curr. Liab. | – | €1 | €0 | -€0 |
| Total Curr. Liab. | – | €4 | €3 | €3 |
| LT Debt | – | €2 | €2 | €2 |
| Deferred Rev, NC | – | €0 | €0 | €0 |
| Deferred Tax Liab, NC | – | €0 | €0 | €0 |
| Other NC Liab. | – | €0 | €0 | €0 |
| Total NC Liab. | – | €2 | €2 | €2 |
| Other Liabilities | – | €0 | €0 | €0 |
| Cap. Leases | – | €0 | €0 | €0 |
| Total Liabilities | – | €5 | €4 | €5 |
| Equity | – | – | – | – |
| Pref Stock | – | €0 | €0 | €5 |
| Common Stock | – | €2 | €2 | €2 |
| Retained Earnings | – | -€2 | -€3 | -€7 |
| AOCI | – | €1 | €1 | €0 |
| Other Equity | – | -€2 | €0 | -€3 |
| Total Equity | – | -€2 | -€0 | €2 |
| Supplemental Information | – | – | – | – |
| Minority Interest | – | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | – | €4 | €4 | €7 |
| Net Debt | €0 | €2 | €3 | €2 |